Companies / PFE vs VTRS
PFE vs VTRS: Pfizer and Viatris
Pfizer (PFE) reported $62.6B in revenue against a 12.4% net margin, while Viatris (VTRS) reported $14.3B at a -24.6% net margin, most recently.
| Metric | PFE | VTRS |
|---|---|---|
| Revenue | $62.6B | $14.3B |
| Net Income | $7.8B | $-3.5B |
| Gross Margin | 74.3% | 35.1% |
| Operating Margin | — | -18.6% |
| EPS (Diluted) | $1.36 | $-3.00 |
| Free Cash Flow | $9.1B | $1.9B |
| Total Debt | $64.8B | $14.4B |
| P/E Ratio | 18.3× | n/m |
| P/B Ratio | n/m | n/m |
| Stock Price | $29.90 | $19.00 |
Free: last 5 years
| Fiscal year | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| PFE Revenue | ••••• | ••••• | ••••• | $81.3B | $101.2B | $59.6B | $63.6B | $62.6B |
| VTRS Revenue | ••••• | ••••• | ••••• | $17.9B | $16.3B | $15.4B | $14.7B | $14.3B |